Cytek Biosciences, Inc. - COM (CTKB)

Historical Portfolio Holders from Q3 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
75M
Holdings value Q3 2024
$415M
Value change Q3 2024
-$14.5M
Grand Portfolio weight change Q3 2024
0%
Number of holders
134
Number of buys Q3 2024
84
Number of sells Q3 2024
-42
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 75M $415M -$14.5M $5.54 134
2024 Q2 76.2M $425M -$33.3M $5.58 125
2024 Q1 80.5M $540M +$11.1M $6.71 118
2023 Q4 78.9M $720M +$18M $9.12 101
2023 Q3 77.5M $428M -$3.53M $5.52 107
2023 Q2 77M $658M +$70M $8.54 100
2023 Q1 68.5M $630M +$39.1M $9.19 100
2022 Q4 64M $654M +$29.4M $10.21 100
2022 Q3 61M $898M +$127M $14.72 87
2022 Q2 52.9M $568M +$56.3M $10.73 81
2022 Q1 47.7M $515M +$122M $10.78 72
2021 Q4 35M $572M -$4.87M $16.32 51
2021 Q3 34.4M $744M +$744M $21.41 53